Contribution of calcium dysregulation to impaired coronary artery contraction in Zucker diabetic fatty rats.

  • Published In: Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 2. P. 158 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Liu, Lin; Yang, Hui; Kuang, Su‐Juan; Zhang, Li; Zhou, Meng‐Yuan; Zeng, Peng; Zhang, Meng‐Zhen; Rao, Fang; Zhou, Zhi‐Ling; Deng, Chun‐Yu 3 of 3

Abstract

Diabetic coronary artery injury is closely associated with Ca2+ dysregulation, although the underlying mechanism remains unclear. This study explored the role and mechanism of Ca2+ handling in coronary artery dysfunction in type 2 diabetic rats. Zucker diabetic fatty (ZDF) rats were used as the type 2 diabetes mellitus model. The contractility of coronary artery rings induced by KCl, CaCl2, 5‐HT and U46619 was significantly lower in ZDF rats than in Zucker lean rats. Vasoconstriction induced by 5‐HT and U46619 was greatly inhibited by nifedipine. However, in the presence of 1 μM nifedipine or in the Ca2+‐free KH solution containing 1 μM nifedipine, there was no difference in the vasoconstriction between Zucker lean and ZDF rats. Store‐operated calcium channels (SOCs) were not involved in coronary vasoconstriction. The downregulation of contractile proteins and the upregulation of synthesized proteins were in coronary artery smooth muscle cells (CASMCs) from ZDF rats. Metformin reversed the reduction of vasoconstriction in ZDF rats. Taken together, L‐type calcium channel is important for regulating the excitation–contraction coupling of VSMCs in coronary arteries, and dysregulation of this channel contributes to the decreased contractility of coronary arteries in T2DM. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Clinical & Experimental Pharmacology & Physiology. 2023/02, Vol. 50, Issue 2, p158
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2023
  • ISSN:0305-1870
  • DOI:10.1111/1440-1681.13733
  • Accession Number:161103757
  • Copyright Statement:Copyright of Clinical & Experimental Pharmacology & Physiology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.